Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-08-17FDA Approved: ROSUVASTATIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA supplemental application approval for Camber Pharmaceuticals' rosuvastatin product.
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids [Phase 3]
Phase 3 trial results for Enlicitide Decanoate (MK-0616), an oral PCSK9 inhibitor, in adults with hypercholesterolemia; study completed with…
-
FDA approval · 2026-08-05FDA Approved: SIMVASTATIN — Supplemental Application (WATSON LABS TEVA)
A supplemental application approval for simvastatin by Watson Labs Teva, indicating a formulation/label change under an ANDA submission.
-
FDA label_change · 2026-07-31FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA supplemental approval for rosuvastatin calcium from Torrent Pharmaceuticals Limited.
-
FDA approval · 2026-07-31FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
Supplemental approval for rosuvastatin calcium by Rising Pharma Holdings, Inc..
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1) [Phase 2]
Phase 2 clinical trial in children aged 6 to 17 with heterozygous familial hypercholesterolemia evaluating once-daily bempedoic acid (CLEAR …
-
EMA approval · 2026-07-09EMA Authorised: Evkeeza (Evinacumab) — Ultragenyx Germany GmbH
EMA authorised Evkeeza (evinacumab) for hypercholesterolemia under Ultragenyx Germany GmbH, decision dated 08/07/2026.
-
EMA approval · 2026-06-25EMA Authorised: Lojuxta (Lomitapide) — Chiesi Farmaceutici SpA
LOJUJTA (lomitapide) has been authorised in the EU for hypercholesterolemia by Chiesi Farmaceutici, marking an approval decision.
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Update: A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R [Phase 3]
Phase 3 clinical trial update for AG2304T and AG2304R in hypercholesterolemia has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia [Phase 4]
Phase 4 clinical trial in India evaluating the safety and effectiveness of inclisiran sodium for primary hypercholesterolemia or mixed dysli…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
This completed NHLBI clinical trial evaluated lipoprotein metabolism in normal volunteers and individuals with high lipoprotein levels, prov…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD [NA]
Clinical trial update describing a study of a moderate-intensity statin plus ezetimibe in patients with chronic kidney disease and atheroscl…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes [Phase 3]
Enlicitide Decanoate (MK-0616) is being studied as an oral PCSK9 inhibitor in the Phase 3 CORALreef Outcomes cardiovascular outcomes trial (…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab
This real-world clinical trial update reports on long-term adherence and persistence to inclisiran, evolocumab, and alirocumab among patient…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Specified Drug-use Survey of Leqvio for s.c. Injection.
This clinical trial update reports a specified drug-use survey of Leqvio (inclisiran) for subcutaneous injection, with the study currently a…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile [NA]
A clinical trial is evaluating the effects of corn oil and avocado oil on cardiometabolic risk factors in adults with hypercholesterolemia; …
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting
A completed non-interventional study assessing Inclisiran (Leqvio) and other lipid-lowering therapies in real-world treatment of hypercholes…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia [Phase 4]
This Phase 4 trial compares Inclisiran (KJX839) vs placebo in adults with hypercholesterolemia on ongoing lipid-lowering therapy to assess e…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Dachundou No Sugar Added Soymilk for Lipid Modulation [NA]
A completed clinical trial from National Taiwan Sport University evaluating Dachundou No Sugar Added Soymilk for lipid modulation in individ…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Pharmacogenomic Informed Statin Prescribing [NA]
A clinical trial is investigating pharmacogenomic informed statin prescribing for hypercholesterolemia. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Efficacy of Lactobacillus Mucosae DPC6426 on Blood-lipids [NA]
A completed clinical trial evaluated the effect of the probiotic Lactobacillus mucosae DPC6426 on blood lipid levels in individuals with hyp…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome [Phase 4]
Phase 4 clinical trial comparing triple versus dual lipid-lowering therapy to reduce LDL-C in patients with acute coronary syndrome; not yet…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Long-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular Disease
Verve Therapeutics reports long-term follow-up data from participants treated with its investigational gene-editing therapy for cardiovascul…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia [Phase 3]
Phase 3 clinical trial evaluating SYH2053 as monotherapy for non-familial hypercholesterolemia or mixed hyperlipidemia in Chinese participan…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Pharmacokinetics of Butyrate Tablet BKR-017
The completed clinical trial provides pharmacokinetic data for the Butyrate Tablet BKR-017 in hypercholesterolemia. It summarizes absorption…